179 related articles for article (PubMed ID: 33824462)
1. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
[TBL] [Abstract][Full Text] [Related]
3. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
4. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy.
Singh K; Sung CJ; Quddus MR
Breast J; 2020 Dec; 26(12):2350-2356. PubMed ID: 33047861
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Shamir ER; Chen YY; Krings G
Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
[TBL] [Abstract][Full Text] [Related]
6. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
Harinath L; Villatoro TM; Clark BZ; Fine JL; Yu J; Carter GJ; Diego E; McAuliffe PF; Mai P; Lu A; Zuley M; Berg WA; Bhargava R
Mod Pathol; 2024 Apr; 37(4):100462. PubMed ID: 38428736
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes.
Savage JL; Jeffries DO; Noroozian M; Sabel MS; Jorns JM; Helvie MA
AJR Am J Roentgenol; 2018 Aug; 211(2):462-467. PubMed ID: 29894223
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision.
Guo T; Wang Y; Shapiro N; Fineberg S
Clin Breast Cancer; 2018 Aug; 18(4):e449-e454. PubMed ID: 29102711
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
Calle C; Kuba MG; Brogi E
Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast.
Fasola CE; Chen JJ; Jensen KC; Allison KH; Horst KC
Breast J; 2018 Jan; 24(1):66-69. PubMed ID: 28929550
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
13. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
14. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.
Desai AA; Jimenez RE; Hoskin TL; Day CN; Boughey JC; Hieken TJ
Ann Surg Oncol; 2018 Oct; 25(10):3064-3068. PubMed ID: 29947004
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
[TBL] [Abstract][Full Text] [Related]
17. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
18. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
Chen YY; Hwang ES; Roy R; DeVries S; Anderson J; Wa C; Fitzgibbons PL; Jacobs TW; MacGrogan G; Peterse H; Vincent-Salomon A; Tokuyasu T; Schnitt SJ; Waldman FM
Am J Surg Pathol; 2009 Nov; 33(11):1683-94. PubMed ID: 19701073
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.
Flanagan MR; Rendi MH; Calhoun KE; Anderson BO; Javid SH
Ann Surg Oncol; 2015 Dec; 22(13):4263-9. PubMed ID: 25893410
[TBL] [Abstract][Full Text] [Related]
20. Observation versus excision of lobular neoplasia on core needle biopsy of the breast.
Schmidt H; Arditi B; Wooster M; Weltz C; Margolies L; Bleiweiss I; Port E; Jaffer S
Breast Cancer Res Treat; 2018 Apr; 168(3):649-654. PubMed ID: 29299726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
